Trip is aiming for a billion-dollar ‘unicorn’ valuation by 2027 as the rapidly growing functional soft drinks brand continues to take the US market by storm.
It comes as the business filed the first full set of financial results at Companies House since married founders Olivia Ferdi and Daniel Khoury launched Trip in 2019.
Net revenues rocketed 132% higher to £50.9m in the year to 28 February 2026 on the back of further distribution gains in the UK and gathering momentum in the US.
Trip said it exited the 2025 calendar year with a sales run rate of close to £90m and forecasted it would exceed £150m in 2026.
Companies House accounts revealed US turnover jumped from just £550k in 2024/25 to £7.2m in the latest financial year. Trip added the US run rate was now above $30m (£22m) and is expected to surpass $75m (£56m) this year.
The business claimed it was on track to be worth $1bn in the first half of 2027, a considerable increase from a $300m valuation at the time of $40m fundraising in November.
“We created Trip on a mission to help a billion people find calm in today’s modern chaos,” Ferdi told The Grocer.
“Building the brand on a global scale is an important step in this journey and we’ve been overwhelmed by the incredible response from our US community. Trip’s hyper-growth reflects the major shifts in consumer drinking behaviour playing out on shelves, in bars and in homes.”
Trip initially broke into the US market in 2021 with distribution in selected premium accounts. Today, the brand is sold nationwide in 15,000 stores and across all six major retail chains: Walmart, Costco, Target, Albertsons, Whole Foods and Sprouts.
Entry into the US has needed heavy investment, but, despite higher operational costs and upfront slotting fees required to secure shelf space in the market, gross profit margins at Trip rose by three percentage points to 45% thanks to soaring sales and supply chain efficiencies.
But as sales shot up so too did administrative expenses, almost doubling from £13m to £24.5m in the year. It pushed Trip to an operating loss of £1.3m in FY26, an improvement on the £3.8m recorded in the prior year.
Excluding the US business, Trip said it attained a net profit margin of 15%.
Total profit for the year came in at £133k, thanks to a £1.2m gain in deferred tax racked up from unused tax losses.
On an underlying cash basis, Trip said it recognised an adjusted profit of £2.3m for the year, a reversal from a £1.5m adjusted loss in FY25. The figure excludes £2.1m of non-cash share-based bonuses awarded to staff and discounted shares for celebrity investors and ambassadors, which are included in administrative expenses on the P&L.
Trip uses enterprise management incentives (EMI) schemes to grant employees share options, which can be exercised after meeting certain targets and conditions, including time served.
About 90% of sales at Trip now come from its non-CBD Mindful Blend range containing magnesium and botanicals, debuted in 2024. The brand has continued expand its offering, pushing into functional hydration in October 2025 with the addition of a magnesium and electrolytes powder. And it added a new Dream Blend range of sleep supplements earlier this year.
No comments yet